Medical Education in Prostate Cancer
Medical Education in Prostate Cancer
At Johnson & Johnson, our ambition is to help eliminate prostate cancer. Through collaboration with patients, caregivers, and healthcare professionals – including leading specialists – we are driven to make our ambition a reality. With over 30 years of innovation in oncology, we are working to get in front of prostate cancer by harnessing the power of precision medicine and developing the next wave of therapeutics.
Our prostate cancer platform provides up-to-date resources, tools and expert insights to support informed decision-making.
Prostate Cancer: Progress in motion
Featured Prostate Cancer Events
Join our upcoming symposia and webinars hosted by our leading specialists. Register for events and access to post event recordings and materials available exclusively for J&J Medical Cloud users.
12-16 September 2026
ECP 2026
Stockholm, Sweden
We're excited to host a GU medical education industry satellite symposium at ECP 2026. Join us in Stockholm for engaging discussions and expert insights in GU oncology.
23-27 October 2026
Join us at ESMO 2026 as we look forward to sharing insights and engaging in meaningful medical education - details to come
ESMO 2026
Madrid, Spain
Join us at ESMO 2026 as we look forward to sharing insights and engaging in meaningful medical education - details to come
5-8 November 2026
EMUC 2026
Brussels, Belgium
We look forward to EMUC 2026, where we will deliver a dedicated prostate cancer medical education symposium, with insights and full programme details coming soon
Register or sign in for J&J Medical Cloud to unlock access to upcoming events, stay updated on the latest educational opportunities, and connect with a network of healthcare professionals.Â
Recently Added
Explore the latest educational content on our website, featuring expert-led sessions, insights from KOLs, and practical tools designed to support your continuous learning and enhance your clinical practice.
EAU 2026
Two dynamic sessions featuring a Prostate Cancer Symposium focused on evolving standards of care through multidisciplinary, case-based discussion, and a Diversity in GU Workshop sharing global insights and practical strategies to advance diversity in GU medicine.
ESMO 2025
The power of precision medicine: Transforming patient outcomes in GU oncology
An expert panel – including Dr. Elena Castro, Prof. Dr. Axel Heidenreich, and Dr. Alejo RodrÃguez-Vida – examine key clinical considerations in GU cancer care.
EMUC 2025
Our prostate cancer session – ‘Driving optimal patient outcomes with personalised strategies in mHSPC’ – examines how PSA response guides optimal care in mHSPC and highlights strategies to improve outcomes in HRR-mutant disease.
Key Highlights
Johnson & Johnson’s Young Experts in Science (YES) Meeting
Our annual meeting - for those earlier in their career specialisation in prostate cancer, focuses on networking, interactive scientific discussions, and enhancing specific skills to improve patient care across the EMEA region by best practice sharing.
Introducing J&J withMe
A patient-centric platform designed to support patients throughout their healthcare journey. It provides personalised, high-quality content and services to enhance patient engagement.
By empowering informed, proactive patients, J&J withMe helps improve treatment outcomes.
Learn how this platform can strengthen your patient relationships: explore J&J withMe today!
APCCC 2026
Johnson & Johnson - A proud Gold Sponsor of APCCC 2026 - a great opportunity for physicians to connect with leading experts from around the world.
Prostate Cancer Learning Centre
Discover educational content designed to enhance your daily practice. Our Learning Centre is dedicated to addressing the evolving needs of healthcare professionals and fostering the diverse skill set essential for delivering high-quality care.
Events Centre
Stay informed with our Event Centre – your hub for medical education events, expert faculty interviews, and clinical insights. Browse on-demand content from past events and hear from leaders shaping patient care.
Expert Insights: Answers from Key Opinion Leaders
Gain valuable insights from leading experts in the field as they share their knowledge on key topics and provide informed answers to common questions. Stay informed and enhance your understanding with expert perspectives!
How is prostate cancer treatment becoming more personalised earlier in the disease course?
How is prostate cancer treatment becoming more personalised earlier in the disease course?
ASCO 2026: Latest in prostate cancer - filmed at ASCO 2026
Prof. Eleni Efstathiou, Prof. Boris Hadaschik, Dr. Mary-Ellen Taplin and Prof. Axel Merseburger discuss how recent trials support earlier treatment intensification and more personalised, biomarker-driven approaches in prostate cancer.
Are emerging innovations reshaping mHSPC treatment and challenging current triple therapy strategies in HRR/BRCA patients?
Are emerging innovations reshaping mHSPC treatment and challenging current triple therapy strategies in HRR/BRCA patients?
Targeted vs. non-targeted therapy for mHSPC: Disease awareness video - filmed at ESMO 2025
Prof. Gero Kramer and Dr. Ercan Müldür discuss new developments in mHSPC and the evolving role of triple therapy approaches for patients with HRR/BRCA alterations.
Held in German with subtitles, accessible for all to view, learn and localise.
How can clinicians support patients in navigating the emotional and sexual challenges of prostate cancer?
How can clinicians support patients in navigating the emotional and sexual challenges of prostate cancer?
Patient and oncologist conversations on the impact of PSA and the importance of psychosexual support
Listen as patient Tony Collier, discusses with Prof. Alison Birtle some of the challenges of living with prostate cancer including the impact of treatment and the importance of open conversations to support sexual health, intimacy, and overall quality of life.
How is precision medicine reshaping prostate cancer management?Â
How is precision medicine reshaping prostate cancer management?Â
Best practice in precision medicine for prostate cancer - filmed at ESMO 2025
Dr. Elena Castro, Dr. Pasquale Rescigno, Prof. Gert Attard and Prof. Axel Heidenreich discuss how personalised approaches, genomic testing, and targeted therapies are transforming prostate cancer care and improving patient outcomes.
What is the value of earlier testing in metastatic prostate cancer?
What is the value of earlier testing in metastatic prostate cancer?
The importance of early testing in metastatic prostate cancer (mPC) – filmed at ASCO 2025
Prof. Eleni Efstathiou, Prof. Gert Attard, Dr. Elena Castro, and Dr. Brigida Maiorano examine the latest trials and discuss the need for earlier testing in mPC to aid treatment decisions.
What new mechanisms of action are coming to the prostate cancer space?
What new mechanisms of action are coming to the prostate cancer space?
New mechanisms of action in prostate cancer treatment – filmed at ASCO 2025
Dr. Joaquin Mateo, Dr. Andrew Parsonson, and Dr. Capucine Baldini discuss promising mechanisms of action in the prostate cancer space, including antibody-drug conjugates, bispecific antibodies, and combination therapies.
Note: To access more expert insights, you can register or sign in to J&J Medical Cloud. Stay informed about the latest educational resources and updates from Johnson & Johnson Innovative Medicine by signing up for our communications.
Our Commitment
Therapeutic Areas
Our scientists and researchers are pioneering the path from lab to life and championing patients each step of the way.
Expert-Driven Education
Our educational programs are developed and reviewed in partnership with a global network of healthcare leaders.
Support‑ Focused
We work with medical societies to support joint initiatives that enhance healthcare outcomes and foster professional education.
Connecting Scientific Expertise
Supporting healthcare professionals to engage in ongoing discussions about the latest scientific advancements.
Our Responsibility to Medical Education
Stay in Touch
We value your connection. Sign up to stay informed about the latest educational resources, and updates. By subscribing, you'll receive timely notifications and exclusive content tailored to your interests.
Contact us
To report an Adverse Event (medication side-effect) or a Product Quality Complaint (an issue with one of our products), please select the appropriate link from the Contact dropdown menu. To submit a medical information request, choose the Medical Information page.
Abbreviations
BRCA, breast cancer gene; GU, genitourinary; HRR, homologous recombinant repair; mHSPC, metastatic hormone-sensitive prostate cancer; PSA, prostate-specific antigen.
CP-540401 - July 2026
Janssen Pharmaceutica NV
